# Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity

> **NCT03246230** · NA · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 911 (actual)

## Conditions studied

- Newborn Vaccine Immunogenicity

## Interventions

- **BIOLOGICAL:** Hepatitis B vaccine (HBV)
- **BIOLOGICAL:** Bacillus Calmette-Guérin (BCG)

## Key facts

- **NCT ID:** NCT03246230
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-06
- **Primary completion:** 2022-08-29
- **Final completion:** 2022-08-29
- **Target enrollment:** 911 (ACTUAL)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246230, "Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03246230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*